Perspective Therapeutics, Inc.

AMEX:CATX

Medical - Devices

Healthcare
$0.78 +0.50%

+$0.02 today

Market cap
$94.67M
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$107.27
52W Low $1.96High $6.16

Volume 1.84M

Average 1.44M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$82.48M

FY 2025 · Annual

Investing Cash Flow

$41.23M

FY 2025 · Annual

Financing Cash Flow

$10.30M

FY 2025 · Annual

-96.4% YoY

Cash Flow Statement

USD
Metric
FY 2021
Jun 2022
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(7.27M)(14.67M)(46.51M)(79.28M)(103.12M)
Depreciation & Amortization248K344K946K2.31M3.25M
Deferred Income Tax0(1.68M)(2.65M)(2.1M)(793K)
Stock-Based Compensation1.09M1.34M3.74M5.39M8.97M
Change in Working Capital(1.85M)338K2.3M31.81M1.68M
Accounts Receivables405K490K(426K)1.05M(32K)
Inventory(2.67M)(152K)359K11K0
Accounts Payables236K01.58M1.89M147K
Other Working Capital182K(28K)779K29.74M1.57M
Other Non-Cash Items77K472K5.27M55.39M7.53M
Operating Cash Flow(7.71M)(12.17M)(36.91M)(18.29M)(82.48M)
Capital Expenditures(266K)(302K)(1.07M)(54.41M)(12.75M)
Acquisitions (Net)002.7M00
Purchases of Investments000(243.51M)(119.84M)
Sales of Investments0022.76M0173.95M
Other Investing Activities(18K)(57.38M)(18K)78.99M(135K)
Investing Cash Flow(284K)(57.68M)24.37M(218.93M)41.23M
Debt Repayment——(68K)(48K)(52K)
Common Stock Issued56K0364K275.81M10.36M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities056K489K289.39M0
Financing Cash Flow56K56K785K289.39M10.31M
Effect of Forex Changes061.86M000
Net Change in Cash(7.94M)182K(46.65M)52.16M(30.95M)
Free Cash Flow(7.98M)(12.47M)(37.99M)(72.71M)(95.23M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$103.1M
+ D&A$3.3M
+ Stock-Based Comp$9.0M
- Deferred Tax-$793.0K
+ Working Capital$1.7M
+ Other Non-Cash$7.5M
= Operating Cash Flow-$82.5M
- Capex-$12.7M
= Free Cash Flow-$95.2M

Analysis

FY2025 free cash flow is -$95.2M. FCF conversion is 92.4% of net income. Operating cash flow was -$82.5M, with capex of -$12.7M. The largest bridge item is Capex at -$12.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
SC 13D/ASC 13D/A filingNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 9, 2026

Does CATX generate free cash flow?

Perspective Therapeutics, Inc. (CATX) generated -$95.23M of free cash flow in fiscal 2025.

How much operating cash flow does CATX produce?

Operating cash flow was -$82.48M, before capital expenditures of $12.75M.